Study: Race Influences Warfarin Dose
May 29, 2015
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology (ASH), proposes race-specific equations to help clinicians better calculate warfarin dosage.
Study: Blood Thinner Safe for Cancer Patients with Brain Metastases
May 18, 2015
Cancer patients with brain metastases who develop blood clots may safely receive blood thinners without increased risk of dangerous bleeding, according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).
ASH Agenda for Hematology Research Identifies Top Priorities for Scientific Discovery
Apr 29, 2015
The American Society of Hematology, the world’s largest professional society committed to the study and treatment of blood disorders, today issued a report urging scientists and funding institutions to coordinate their efforts around six research areas with the strongest potential to make a dramatic impact on the care of patients with a wide range of diseases.